v84a4ax

Property	Value
?:abstract	Abstract The coronavirus disease 2019 (COVID-19) outbreak has created unprecedent challenges for healthcare systems worldwide. Oncology services have been reorganized to decrease the risk of nosocomial acquisition of SARS-CoV-2, but changes in treatment pathways and follow-up cancer care can result in patients receiving suboptimal or delayed care. Herein, we describe a cross-sectional nested cohort study conducted to evaluate delays in care for patients with head and neck cancer (HNC) in post-treatment follow-up or palliative care during the COVID-19 pandemic in Northeast Brazil and its impact on health outcomes. Information was extracted from medical records and supplemented by telephone interviews. We compared the following health outcomes: self-perception of anxiety or sadness, fear of COVID-19 infection, cancer-related complications during social isolation, self-medication, diagnosis of COVID-19, and death between patients with and without delayed cancer care. The Mann-Whitney U test was used to compare distributions of continuous variables and the Fisher exact test was used for categorical variables. Thirty-one HNC patients were included in the study, and no case of confirmed SARS-CoV-2 was found. Delayed cancer care due to restriction in health services was reported in 58.1% of cases, and there was no report of telemedicine use during the COVID-19 outbreak. Cancer-related complications during the COVID-19 pandemic were described for most patients (67.7%) and included pain or discomfort, swelling, and dyspnea. Eight (25.8%) patients reported use of prescribed morphine or codeine to manage pain and six (19.4%) patients reported self-medication with over-the-counter (OTC) non-steroidal anti-inflammatory drugs (NSAIDs). We found an association between delayed HNC care and the use of self-medication (p = 0.028). This study indicated that patients with delayed HNC care during the COVID-19 outbreak are more likely to use self-medication with NSAIDs for pain management. Better strategies to follow HNC patients in socioeconomically disadvantaged communities need to be discussed and implemented. The coronavirus disease 2019 (COVID-19) outbreak has created unprecedent challenges for healthcare systems worldwide Oncology services have been reorganized to decrease the risk of nosocomial acquisition of SARS-CoV-2, but changes in treatment pathways and follow-up cancer care can result in patients receiving suboptimal or delayed care Herein, we describe a cross-sectional nested cohort study conducted to evaluate delays in care for patients with head and neck cancer (HNC) in post-treatment follow-up or palliative care during the COVID-19 pandemic in Northeast Brazil and its impact on health outcomes Information was extracted from medical records and supplemented by telephone interviews We compared the following health outcomes: self-perception of anxiety or sadness, fear of COVID-19 infection, cancer-related complications during social isolation, self-medication, diagnosis of COVID-19, and death between patients with and without delayed cancer care The Mann-Whitney U test was used to compare distributions of continuous variables and the Fisher exact test was used for categorical variables Thirty-one HNC patients were included in the study, and no case of confirmed SARS-CoV-2 was found Delayed cancer care due to restriction in health services was reported in 58 1% of cases, and there was no report of telemedicine use during the COVID-19 outbreak Cancer-related complications during the COVID-19 pandemic were described for most patients (67 7%) and included pain or discomfort, swelling, and dyspnea Eight (25 8%) patients reported use of prescribed morphine or codeine to manage pain and six (19 4%) patients reported self-medication with over-the-counter (OTC) non-steroidal anti-inflammatory drugs (NSAIDs) We found an association between delayed HNC care and the use of self-medication (p = 0 028) This study indicated that patients with delayed HNC care during the COVID-19 outbreak are more likely to use self-medication with NSAIDs for pain management Better strategies to follow HNC patients in socioeconomically disadvantaged communities need to be discussed and implemented The coronavirus disease 2019 (COVID-19) outbreak has created unprecedent challenges for healthcare systems worldwide. Oncology services have been reorganized to decrease the risk of nosocomial acquisition of SARS-CoV-2, but changes in treatment pathways and follow-up cancer care can result in patients receiving suboptimal or delayed care. Herein, we describe a cross-sectional nested cohort study conducted to evaluate delays in care for patients with head and neck cancer (HNC) in post-treatment follow-up or palliative care during the COVID-19 pandemic in Northeast Brazil and its impact on health outcomes. Information was extracted from medical records and supplemented by telephone interviews. We compared the following health outcomes: self-perception of anxiety or sadness, fear of COVID-19 infection, cancer-related complications during social isolation, self-medication, diagnosis of COVID-19, and death between patients with and without delayed cancer care. The Mann-Whitney U test was used to compare distributions of continuous variables and the Fisher exact test was used for categorical variables. Thirty-one HNC patients were included in the study, and no case of confirmed SARS-CoV-2 was found. Delayed cancer care due to restriction in health services was reported in 58.1% of cases, and there was no report of telemedicine use during the COVID-19 outbreak. Cancer-related complications during the COVID-19 pandemic were described for most patients (67.7%) and included pain or discomfort, swelling, and dyspnea. Eight (25.8%) patients reported use of prescribed morphine or codeine to manage pain and six (19.4%) patients reported self-medication with over-the-counter (OTC) non-steroidal anti-inflammatory drugs (NSAIDs). We found an association between delayed HNC care and the use of self-medication (p = 0.028). This study indicated that patients with delayed HNC care during the COVID-19 outbreak are more likely to use self-medication with NSAIDs for pain management. Better strategies to follow HNC patients in socioeconomically disadvantaged communities need to be discussed and implemented.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/3v84a4ax_hasAnnotation_C0003211> <https://research.tib.eu/covid-19/entity/3v84a4ax_hasAnnotation_C0003467> <https://research.tib.eu/covid-19/entity/3v84a4ax_hasAnnotation_C0006826> <https://research.tib.eu/covid-19/entity/3v84a4ax_hasAnnotation_C0013231> <https://research.tib.eu/covid-19/entity/3v84a4ax_hasAnnotation_C0013404> <https://research.tib.eu/covid-19/entity/3v84a4ax_hasAnnotation_C0030193> <https://research.tib.eu/covid-19/entity/3v84a4ax_hasAnnotation_C0278996> <https://research.tib.eu/covid-19/entity/3v84a4ax_hasAnnotation_C0596237> <https://research.tib.eu/covid-19/entity/3v84a4ax_hasAnnotation_C1825598> <https://research.tib.eu/covid-19/entity/3v84a4ax_hasAnnotation_C2364135> <https://research.tib.eu/covid-19/entity/3v84a4ax_hasAnnotation_C3470496> <https://research.tib.eu/covid-19/entity/3v84a4ax_hasAnnotation_C5203676>
?:creator	<https://research.tib.eu/covid-19/entity/MAHL%2C_Claudiane%3B_MELO%2C_Lu%C3%ADs_Ricardo_Santos_de%3B_ALMEIDA%2C_Maria_Helena_Andrade%3B_CARVALHO%2C_Catarina_Sampaio%3B_SANTOS%2C_Lois_Lene_Silva%3B_NUNES%2C_Paula_Santos%3B_QUINTANS-J%C3%9ANIOR%2C_Lucindo_Jos%C3%A9%3B_ARA%C3%9AJO%2C_Adriano_Antunes_de_Souza%3B_SANTOS%2C_Victor_Santana%3B_MARTINS-FILHO%2C_Paulo_Ricardo> <https://research.tib.eu/covid-19/entity/Mahl%2C_Claudiane%3B_Melo%2C_Lu%C3%ADs_Ricardo_Santos_de%3B_Almeida%2C_Maria_Helena_Andrade%3B_Carvalho%2C_Catarina_Sampaio%3B_Santos%2C_Lois_Lene_Silva%3B_Nunes%2C_Paula_Santos%3B_Quintans-J%C3%9Anior%2C_Lucindo_Jos%C3%A9%3B_Ara%C3%9Ajo%2C_Adriano_Antunes_de_Souza%3B_Santos%2C_Victor_Santana%3B_Martins-Filho%2C_Paulo_Ricardo> <https://research.tib.eu/covid-19/entity/Mahl%2C_Claudiane_Melo_Lu%C3%ADs_Ricardo_Santos_de_Almeida_Maria_Helena_Andrade_Carvalho_Catarina_Sampaio_Santos_Lois_Lene_Silva_Nunes_Paula_Santos_Quintans-J%C3%9ANior_Lucindo_Jos%C3%A9_Ara%C3%9AJo_Adriano_Antunes_de_Souza_Santos_Victor_Santana_Martins-Filho_Paulo_Ricardo>
?:journal	Braz._oral_res._(Online) Braz_Oral_Res
?:license	unk
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/3v84a4ax_HAS_C0009214_TREATS_C0030193> <https://research.tib.eu/covid-19/entity/3v84a4ax_HAS_C0026549_TREATS_C0030193> <https://research.tib.eu/covid-19/entity/3v84a4ax_HAS_C0278996_COEXISTS_WITH_C5203670>
?:source	WHO
?:title	Delay in head and neck cancer care during the COVID-19 pandemic and its impact on health outcomes
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:who_covidence_id	#1022914 #745361 #983837
?:year	2020

Property

Value

?:abstract

Abstract The coronavirus disease 2019 (COVID-19) outbreak has created unprecedent challenges for healthcare systems worldwide. Oncology services have been reorganized to decrease the risk of nosocomial acquisition of SARS-CoV-2, but changes in treatment pathways and follow-up cancer care can result in patients receiving suboptimal or delayed care. Herein, we describe a cross-sectional nested cohort study conducted to evaluate delays in care for patients with head and neck cancer (HNC) in post-treatment follow-up or palliative care during the COVID-19 pandemic in Northeast Brazil and its impact on health outcomes. Information was extracted from medical records and supplemented by telephone interviews. We compared the following health outcomes: self-perception of anxiety or sadness, fear of COVID-19 infection, cancer-related complications during social isolation, self-medication, diagnosis of COVID-19, and death between patients with and without delayed cancer care. The Mann-Whitney U test was used to compare distributions of continuous variables and the Fisher exact test was used for categorical variables. Thirty-one HNC patients were included in the study, and no case of confirmed SARS-CoV-2 was found. Delayed cancer care due to restriction in health services was reported in 58.1% of cases, and there was no report of telemedicine use during the COVID-19 outbreak. Cancer-related complications during the COVID-19 pandemic were described for most patients (67.7%) and included pain or discomfort, swelling, and dyspnea. Eight (25.8%) patients reported use of prescribed morphine or codeine to manage pain and six (19.4%) patients reported self-medication with over-the-counter (OTC) non-steroidal anti-inflammatory drugs (NSAIDs). We found an association between delayed HNC care and the use of self-medication (p = 0.028). This study indicated that patients with delayed HNC care during the COVID-19 outbreak are more likely to use self-medication with NSAIDs for pain management. Better strategies to follow HNC patients in socioeconomically disadvantaged communities need to be discussed and implemented.
The coronavirus disease 2019 (COVID-19) outbreak has created unprecedent challenges for healthcare systems worldwide Oncology services have been reorganized to decrease the risk of nosocomial acquisition of SARS-CoV-2, but changes in treatment pathways and follow-up cancer care can result in patients receiving suboptimal or delayed care Herein, we describe a cross-sectional nested cohort study conducted to evaluate delays in care for patients with head and neck cancer (HNC) in post-treatment follow-up or palliative care during the COVID-19 pandemic in Northeast Brazil and its impact on health outcomes Information was extracted from medical records and supplemented by telephone interviews We compared the following health outcomes: self-perception of anxiety or sadness, fear of COVID-19 infection, cancer-related complications during social isolation, self-medication, diagnosis of COVID-19, and death between patients with and without delayed cancer care The Mann-Whitney U test was used to compare distributions of continuous variables and the Fisher exact test was used for categorical variables Thirty-one HNC patients were included in the study, and no case of confirmed SARS-CoV-2 was found Delayed cancer care due to restriction in health services was reported in 58 1% of cases, and there was no report of telemedicine use during the COVID-19 outbreak Cancer-related complications during the COVID-19 pandemic were described for most patients (67 7%) and included pain or discomfort, swelling, and dyspnea Eight (25 8%) patients reported use of prescribed morphine or codeine to manage pain and six (19 4%) patients reported self-medication with over-the-counter (OTC) non-steroidal anti-inflammatory drugs (NSAIDs) We found an association between delayed HNC care and the use of self-medication (p = 0 028) This study indicated that patients with delayed HNC care during the COVID-19 outbreak are more likely to use self-medication with NSAIDs for pain management Better strategies to follow HNC patients in socioeconomically disadvantaged communities need to be discussed and implemented
The coronavirus disease 2019 (COVID-19) outbreak has created unprecedent challenges for healthcare systems worldwide. Oncology services have been reorganized to decrease the risk of nosocomial acquisition of SARS-CoV-2, but changes in treatment pathways and follow-up cancer care can result in patients receiving suboptimal or delayed care. Herein, we describe a cross-sectional nested cohort study conducted to evaluate delays in care for patients with head and neck cancer (HNC) in post-treatment follow-up or palliative care during the COVID-19 pandemic in Northeast Brazil and its impact on health outcomes. Information was extracted from medical records and supplemented by telephone interviews. We compared the following health outcomes: self-perception of anxiety or sadness, fear of COVID-19 infection, cancer-related complications during social isolation, self-medication, diagnosis of COVID-19, and death between patients with and without delayed cancer care. The Mann-Whitney U test was used to compare distributions of continuous variables and the Fisher exact test was used for categorical variables. Thirty-one HNC patients were included in the study, and no case of confirmed SARS-CoV-2 was found. Delayed cancer care due to restriction in health services was reported in 58.1% of cases, and there was no report of telemedicine use during the COVID-19 outbreak. Cancer-related complications during the COVID-19 pandemic were described for most patients (67.7%) and included pain or discomfort, swelling, and dyspnea. Eight (25.8%) patients reported use of prescribed morphine or codeine to manage pain and six (19.4%) patients reported self-medication with over-the-counter (OTC) non-steroidal anti-inflammatory drugs (NSAIDs). We found an association between delayed HNC care and the use of self-medication (p = 0.028). This study indicated that patients with delayed HNC care during the COVID-19 outbreak are more likely to use self-medication with NSAIDs for pain management. Better strategies to follow HNC patients in socioeconomically disadvantaged communities need to be discussed and implemented.

is ?:annotates of